Dr. Reddy's Laboratories Limited (RDY)
RDYNYSEBiotechnology: Pharmaceutical Preparations
$14.74
+0.0100 (+0.07%) today
Closed, Nov 13, 4:00 PM ET
- Market cap
- $12.31bn
- P/E
- 36.9
- EPS, last 4 quarters
- $0.4000
- Dividend yield
- –
- Day range
- –
- 52-week range
- $11.36 to $15.67
- Average volume
- –
- Previous close
- $14.73
Analysts
2 coveringHold1 buy, 1 hold, 0 sell
Targets a year out average $14.42, -2.2% from here
Earnings
next estimate $0.1500Next report
Dec 2025
0.0%
Mar 2026
-33.3%
Jun 2026
-64.7%
Sep 2026
-25.0%
estimate reported, and the surprise
Financials
No quarterly figures from the source.
News
8 latest- Weekly Buzz: RDY, LUPIN, SUNPHARMA Score FDA Wins; AGIO, RARE Slash Jobs; CVS Plots Split RTTNews · Nov 6, 2026
- Dr. Reddy's Laboratories Limited Receives Marketing Authorization for Generic Semaglutide Injection in BrazilFintel · Nov 5, 2026
- Dr.Reddy's Wins Brazil Approval For Generic Ozempic Alternative RTTNews · Nov 5, 2026
- Dr. Reddy's Laboratories Limited Allots 5,91,270 Equity Shares Under Employees ADR Stock Options Scheme, 2007Fintel · Nov 4, 2026
- Reddy's Gets Tentative FDA Nod For Twice-Yearly HIV Prevention Shot At $40 A Year RTTNews · Nov 3, 2026
- Dr. Reddy's Laboratories Limited Announces USFDA Classifies FTO-SEZ Process Unit-02 Inspection as Voluntary Action IndicatedFintel · Oct 29, 2026
- RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales FallZacks · Oct 26, 2026
- Dr. Reddy's Laboratories: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · Oct 25, 2026
The company
Dr. Reddy's Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of 'Good Health Can't Wait', we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major therapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include - USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first Sustainability Report in 2004.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NYSE
- Region
- Asia
- Website
- drreddys.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.